Please note that injectable weight loss medications are not covered by Medicare for obesity alone
7 Most studies have used a dose of 1 to 20 mg per day
1 GLP-1 receptors are expressed in the human choroid plexus, and it is believed that GLP-1 RAs reduce CSF secretion which leads to lower ICP
Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments
The authors highlight particular concern for women of childbearing age, given the potential for POP transfer to infants via pregnancy and breast milk and conclude that POP mobilization is a clinically relevant side effect of major weight loss that merits further attention.35 Percentage Blood Lipophilic Toxin Increases Following Bariatric Surgery at 12-Months: (Jansen, et al
These changes are also related to improvements in quality of life, as they can alleviate common symptoms such as fatigue, jaundice, and gastrointestinal discomfort in patients with advanced liver disease [44]